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Purpose: To determine the influence of clinical features and Indocyanine green (ICG) angiographic features 
on the visual outcome of patients with myopic sub-foveal choroidal neovascularization (CNV) who received 
photodynamic therapy (PDT). 
Methods: Thirty-six consecutive patients (39 eyes) with myopic CNV who were followed up for more than one 
year after PDT were enrolled in this study. Clinical features included age, gender, refractive error, great linear 
dimension, and subretinal hemorrhage. ICG features included the lesion size, lacquer cracks, 
hypofluorescence surrounding the CNV (dark rim), peripapillary atrophy size, and visible prominent choroidal 
veins under the macula. Linear regression analysis was performed using the change in visual acuity (Δ
logMAR) as the dependent variable and the above factors as independent variables. 
Results: At one-year follow-up after PDT, a younger age (p=0.002) and the presence of a dark rim (p= 0.002) 
were significantly correlated with an improvement of visual acuity (decrement in logMAR) after PDT. Other 
factors had no significant influence on changes in visual acuity.
Conclusions: Younger patients and patients with a dark rim on ICG angiography had a higher chance of 
visual improvement after PDT in myopic CNV.  Korean Journal of Ophthalmology 20(1):18-25, 2006
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Pathologic myopia is a major cause of legal blindness in 
developed countries.1-2 The most common complication leading 
to decreased central vision in pathologic myopia is choroidal 
neovascularization (CNV), which affects 5% to 10% of 
patients with high myopia.3-5 Despite its importance as a 
cause of visual impairment in myopic patients, no effective 
treatments have been established for pathologic myopia 
except photodynamic therapy (PDT).6-7 
Recently, Montero and Ruiz-Moreno8 showed that a 
patient's age at the onset of myopic CNV influenced the 
future prognosis of the disease. The younger patient group 
(≤55 years old) had a better final visual acuity at one-year 
follow-up after PDT than did the older group of patients (>55 
years old). Their study included 31 eyes of 30 patients, and 
the mean age in the entire group was 54.9 ｢Standard Devia-
tion (SD)=14.0｣ years. Ergun and associates9 found in their 
36-patient series that younger patients and patients with 
higher baseline visual acuities had better treatment outcomes 
at the two-year follow-up after PDT. The mean age of the 
patients was 59.7 (SD=15.1) years. Axer-Siegel and associ-
ates10 also demonstrated that the younger myopic CNV patient 
group (<60 years old) had a better final visual acuity and less 
visual loss after PDT. In their study of 29 patients, the mean 
age was 63.1 (SD=14.11) years with a mean follow-up period 
of 11.5 (SD=9.9) months. Based on their observations, they 
concluded that patient age was the most important prognostic 
factor of treatment outcome after PDT. The aforementioned 
studies have some limitations. They included a large number 
of elderly patients, which might cause neovascular degener-
ation of degenerative myopia to be confused with age-related 
macular degeneration. 
In degenerative myopia, blood flow in the choroidal 
vessels is delayed and the choriocapillaries show severe 
circulatory disturbances.11-13 Since new vessels originate from 
the choroids, the hemodynamic characteristics of these 
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Fig. 1. Angiography of a 30-year-old man with myopic sub-foveal CNV in his left eye. At the initial examination, the patient's 
best-corrected visual acuity was 20/200. The refractive error was -9.0 diopters. (1A) An early-phase ICG angiogram revealed the 
hypofluorescence surrounding the CNV (dark rim). (1B) Late-phase ICG angiography showed lacquer cracks radiating from the lesion. At 
the 12-month follow-up, the patient's visual acuity had improved to 20/40. (1C, 1D) ICG angiography showed the decreased size of the 
lesion and a more prominent dark rim. At the 24-month follow-up, the patient's visual acuity remained at 20/40. (1E, 1F) ICG 
angiography also revealed the remaining smaller lesion.
vessels depend on those of the choroids. For example, the 
incidence of neovascularization may increase with the progres-
sion of degenerative changes in myopic eyes. However, the 
development of CNV requires the relative preservation of the 
choriocapillaries.14 It is also known that the fovea is almost 
entirely dependent on choroidal circulation for its nutrition. 
The visual prognosis of myopic CNV after PDT may not 
only be influenced by the characteristics of the CNV, but also 
by the state of the choroid and the choriocapillaries. Indo-
cyanine green (ICG) angiography can better document 
choroidal vessels because of its better penetration of 
near-infrared light into the choroid. However, there have been 
no reports that have identified the ICG findings as a 
prognostic factor for the visual outcome of myopic CNV after 
PDT. 
The ‘dark rim’ was first characterized by Scheider and 
associates.15 They observed the network of choroidal neovas-
cularization within the choroidal hypofluorescent area in ICG 
angiograms using a scanning laser ophthalmoscope. There 
has also been a small number of reports describing a dark 
rim in idiopathic CNV and myopic CNV.15-18 However, no 
reports have investigated the relationship between the 
presence of a dark rim and the visual prognosis of idiopathic 
or myopic CNV.
The purpose of this study was to evaluate the visual 
improvement of myopic CNV when treated with PDT, and 
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Fig. 2. Angiography of the left eye of a 55-year-old man. At the initial examination, the patient's best-corrected visual acuity was 20/200. 
The refractive error was -9.0 diopters. (2A) An early-phase ICG angiography showed a dark rim surrounding the CNV, an adjacent 
small-blocked fluorescence due to hemorrhage and a bifurcate prominent choroidal vein. (2B) Late-phase ICG angiography revealed the 
visible hyperfluorscent choroidal vein on the macula, but no lacquer cracks were seen. (2C, 2D) At the 12-month follow-up, the patient's 
visual acuity had improved to 20/160. The lesion and the dark rim had become less prominent. Persistent prominent choroidal veins were 
noted. (2E, 2F) At the 24-month follow-up, the size of the CNV was enlarged even after receiving PDT five times. The patient's visual 
acuity was decreased to 20/200. 
to establish a relationship between age and visual outcome. 
We also examined other clinical and ICG angiographic 
characteristics as prognostic factors for the visual outcome 
after PDT. 
Materials and Methods
Thirty-eight consecutive patients (for a total of 41 eyes) 
with pathologic myopia and subfoveal CNV who were treated 
with verteporfin (Visudyne, NovartisAG, Basel, Switzerland) 
PDT at Yonsei University Medical Center between May 2002 
and August 2004 were identified. Two patients were excluded 
because they were lost to follow-up, and the remaining 36 
completed at least 12 months of follow-up. The study 
included 39 eyes of these 36 patients. Informed consent was 
obtained from all patients, and approval from the institution's 
ethics committee was not required for this retrospective 
study.
Pathologic myopia was defined as when an eye required 
a distance correction of at least -6.0 diopters (D=spherical 
equivalent). Patients with angioid streaks, evidence of histo-
plasmosis, choroiditis, idiopathic CNV, or other causes of 
CNV were excluded from the study. Subfovea was defined 
as an involvement of the center of the foveolar avascular 
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Fig. 3. ICG angiography of the right eye of a 58-year-old woman. At initial examination, the patient's best-corrected visual acuity was 
20/63. The refractive error was -11.0 diopters. (3A) The mid-phase ICG angiography showed the lesion to be slightly more hyperfluorescent 
than the background. (3B) The late phase revealed dye leakage beyond the previous lesion with multiple lacquer cracks. (3C, 3D) At a 
12-month follow-up, the patient's visual acuity had decreased to 20/200. The ICG angiography showed a similar appearance of the baseline 
ICG angiography despite four treatments of PDT during the previous 12 months. (3E, 3F) At the 24-month follow-up, the patient's visual 
acuity had returned to 20/125. During the 24-month follow-up, she had undergone PDT five times.
zone.
PDT was administered by one surgeon (OW Kwon) 
according to the VIP and TAP study protocol6,7,19,20 with 
follow-ups at one week, one month, and three months after 
the therapy, and then every three months thereafter. If there 
were any signs of fluorescein leakage three months after 
PDT, then the PDT was repeated. Fluorescein angiography 
and ICG angiography were repeated for the initial exami-
nation and at every subsequent follow-up visit.
All patients received comprehensive ocular examinations 
(including dilated fundus photography, fluorescein angio-
graphy and ICG angiography) at the baseline investigation 
and again every three months thereafter. The best-corrected 
visual acuity was measured using a modified ETDRS chart.
The patient characteristics retrieved from the medical 
charts included age, gender, refractive errors, ETDRS visual 
acuity, and the number of treatments. The greatest linear 
dimension (GLD) (including the CNV, area of leakage and 
the area of blocked fluorescence in the lesion, according to 
the TAP study) was measured manually on the fluorescein 
angiograms.19 
Indocyanine green (ICG) angiography was performed with 
a scanning laser ophthalmoscope (HRA, Heidelberg Enginee-
ring, Dossenheim, Germany). The ICG angiograms were 
reviewed by two examiners (SH Byeon and HJ Koh) to 
determine the lesion size on ICG angiography ｢ratio of the 
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Covariate
Univariate Multivariate*
Beta (se) p-value Beta (se) p-value
Age
Gender (female)
Refractive error
Baseline VA
Baseline GLD (µm)
Subretinal hemorrhage
Lesion on ICGA (Disc Area)
Lacquer cracks
Peripapillary atrophy (Disc Area)
Dark rim
Prominent choroidal vein
0.012 (0.003)
0.201 (0.110)
-0.007 (0.015)
-0.148 (0.127)
0.000 (0.000)
-0.027 (0.136)
0.136 (0.091)
0.092 (0.118)
-0.005 (0.024)
-0.333 (0.099)
0.112 (0.115)
0.001
0.075
0.652
0.253
0.145
0.842
0.141
0.444
0.833
0.002
0.340
0.010 (0.003)
-
-
*
-
-
-
-
-
-0.315 (0.093)
-
0.002
-
-
*
-
-
-
-
-
0.002
-
GLD, greatest linear dimension: ICGA, ICG angiography: se, standard error; VA, visual acuity
*Baseline logMAR values were adjusted for the control of the imbalance in multivariate analysis.
Table 1. Twelve-month results of the linear regression models for the single and the combined influence of covariates on 
the change in the logMAR value (ΔlogMAR) from baseline to 12 months (N=39).
Fig. 4. Scattergram of the 12-month results of change in the 
logMAR (ΔlogMAR) after photodynamic therapy according to age 
and the presence of a dark rim.
total area of the lesion divided by the area of the optic disc 
(DA=Disc Area)｣ and any associated findings, including 
hypofluorescence surrounding the CNV (dark rim), lacquer 
cracks, prominent large choroidal veins in the macula, and 
peripapillary choroidal atrophy size.21-24 The presence of an 
ICG angiographic dark rim (hypofluorescence around the 
CNV) was defined as a round-shaped background hypofluore-
scence within which a hyperfluorescent island appeared 
during the early phase (Fig. 1, 2).15-18 Lacquer cracks were 
identified using late-phase ICG angiography (Figures 1 and 
3).16,22 Regarding the presence of visible large choroidal veins 
under the macula, the focal dilation of the choroidal veins in 
the posterior fundus during the early phase of ICG angio-
graphy was defined; some showed hyperfluorescence until the 
late-phase of the angiogram (Fig. 2).16,23 The area of 
peripapillary atrophy (islands of non-perfusion or reduced 
perfusion in the deep choroid in early or late hypoflurore-
scence) was defined as the ratio of the total area of 
peripapillary atrophy divided by the disc area on ICG 
angiography.22,24 
To evaluate the relative impact of the baseline predictors 
(the clinical and ICG angiographic features) on the visual 
outcome, a linear regression analysis was performed. The 
main outcome measure was the change in the logMAR value 
during the follow-up period (ΔlogMAR), which was 
obtained by subtracting the baseline logMAR value from the 
final logMAR value 12 months after PDT. A linear regres-
sion analysis was performed using the change in visual acuity 
(ΔlogMAR) as the dependent variable and the above factors 
as independent variables. The potential prognostic effects 
were assessed using both univariate and multiple linear 
regression analyses. All reported p-values were the results of 
two-sided tests, and p-values ≤0.05 were considered 
statistically significant. SPSS 12.0 software for Windows 
(Chicago, Illinois, USA) was used for statistical calculations.
Results
1. Baseline characteristics of patients
Thirty-nine eyes from 36 patients with subfoveal CNV 
secondary to pathologic myopia had completed 12 months of 
follow-up. All were Korean and 24 (66.7%) were females. 
The mean age of patients at presentation was 44.1 [standard 
deviation (SD)=15.0] years, with a range from 25 to 74 years. 
Refractive errors ranged from -6.00D to -23.00D, and the 
mean was -10.78 (SD=3.80) D. The average number of 
treatments during the 12 months of follow-up was 2.4 (SD 
=1.2). The mean Great linear dimension (GLD) of lesions on 
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Observation Yoshida et al.28 Photodynamic therapy, Byeon et al.
≤40 years (n=26) >40 years (n=47) ≤40 years (n=18) >40 years (n=21)
Age [mean (SD)]
Refractive error (D) [mean (SD)]
Follow-up (month) [mean (SD)]
Baseline logMAR [mean (SD)]
Final logMAR [mean (SD)]
Paired t-test
29.8 (5.7)
-13.6 (4.4)
  82 (29.5)
0.44 (0.39)
0.33 (0.44)
ns
54.6 (9.2)
-13.2 (4.2)
  86 (48.0)
0.89 (0.53)
1.12 (0.42)
P=0.02
30.4 (3.1)
-10.8 (4.9)
  12 (0)
0.74 (0.40)
0.44 (0.34)
P=0.001
56.2 (9.3)
-10.8 (2.7)
  12 (0)
0.89 (0.45)
0.90 (0.52)
P=0.827
SD, standard deviation: ns, not significant.
Table 2. A comparison of the current photodynamic therapy series with another series managed by observation
fluorescein angiography was 1775 (SD=976) µm (range= 400 
-4280) at presentation. Submacular hemorrhages visible on 
fundus photography and fluorescein angiography were found 
in 8 of 39 eyes. The mean area of lesions visible on ICG 
angiography was 0.71 (SD=0.61) DA (range=0.08-2.24). The 
lacquer cracks were found in 27 of 39 eyes. The mean area 
of peripapillary choroidal atrophy on ICG angiography was 
2.0 (SD=2.4) DA. The hypofluorescence surrounding the 
CNV (dark rim) was found in 15 of 39 eyes, and prominent 
large choroidal veins were noted under the macula in 13 of 
39 eyes.
2. Visual outcome at 12-month follow-up
The presenting best-corrected visual acuity measured with 
an ETDRS chart was greater than 20/40 in four (10.3%) eyes, 
from 20/40 to 20/200 in 26 (66.7%) eyes, and less than 
20/200 in nine (23.0%) eyes. The baseline mean logMAR 
was 0.82 (SD=0.43). At the 12-month follow-up, the best- 
corrected visual acuity was greater than 20/40 in six (15.4%) 
eyes, from 20/40 to 20/200 in 25 (64.1%) eyes, and less than 
20/200 in eight (20.5%) eyes. The mean logMAR had 
improved to 0.69 (SD=0.50). 
The change in visual acuity from baseline at the 12-month 
follow-up was six lines or more of visual acuity improvement 
in seven eyes (18%), one to six lines of improvement in 14 
eyes (36%), no change in nine eyes (23%), and a one-line 
or more decrease in visual acuity in nine eyes (23%).
3. Results of regression models
When clinical features including age, gender, refractive 
error, baseline visual acuity, baseline GLD, and submacular 
hemorrhage, and ICG features such as the size of CNV, 
lacquer cracks, area of peripapillary atrophy, dark rim, and 
a prominent large choroidal vein were examined as 
prognostic factors by univariate analysis, both age and the 
presence of a dark rim had a statistically significant effect on 
a change in logMAR(ΔlogMAR) at 12 months (Table 1). On 
a multivariate analysis, age and the presence of a dark rim 
still remained statistically significant at the 12-month 
follow-up (Table 1, Fig. 4).
Discussion
More than 50% of the myopic CNV patients showed visual 
improvement 12 months after PDT. We found that patients 
older than 50 years rarely had visual improvement following 
PDT after 12 months of follow-up. Both the age at onset and 
the ICG angiographic feature (dark rim) were related to a 
change of visual acuity from the baseline. A younger age and 
the presence of a dark rim were good prognostic factors after 
PDT. Other factors such as gender, refractive error, baseline 
visual acuity, baseline GLD, submacular hemorrhage, and 
ICG features (including the size of the CNV, lacquer cracks, 
area of peripapillary atrophy, and a prominent large choroidal 
vein) were not predictive of outcome when the age and 
presence of a dark rim were accounted for. Our series 
contained a relatively large number of patients who had a 
visual improvement after PDT.6,7,8-10,25 This may be due to the 
younger age distribution in our series compared to other 
studies. 
Among our participants, 24 eyes (62%) from 22 patients 
completed a 24-month follow-up. Their baseline charac-
teristics were similar to those who had finished a 12-month 
follow-up (data not shown). Their baseline mean logMAR 
value was 0.89 (SD=0.45). The 24-month mean logMAR 
value improved to 0.80 (SD=0.57). In our 24-month 
follow-up group, a multivariate regression model also showed 
that a younger age (P=0.012) and a dark rim (P=0.031) were 
significantly correlated with an improvement of visual acuity 
at the 24-month follow-up.
Previous reports have suggested that patients who were 
younger at the onset of CNV might be able to retain good 
vision even without any treatment during follow-up. Because 
our study did not have a comparative group, it was not clear 
whether the better visual outcomes of young patients in our 
series were due to an effect of PDT or to the natural 
characteristics of myopic CNV in young patients. Reports on 
the natural history of CNV in high myopia patients vary, and 
most to date provide conflicting information.6,7,26-31 This may 
be because those studies enrolled a variety of eligible 
patients, represented variable lesion topographies, contained 
different patient age distributions, and had variable follow-up 
periods. Our study had similar eligibility criteria and age 
distributions to Yoshida's series,28 which found that younger, 
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myopic CNV patients retained good visual acuity without any 
treatment. Japan and Korea have ethnic and geographic 
similarities as well as a prevalence of high myopia. Yoshida 
examined 63 consecutive patients (73 eyes) with myopic 
CNV, and then divided the patients into two groups 
according to their ages (≤40 and >40 years old). These 
patients were followed for more than three years. For 
comparison, we also divided our patients into two groups at 
the age of 40 (Table 2). In our study, the younger group (≤
40) had significant improvement in visual acuity. In his 
natural history series, even though the younger patients 
retained relatively good visual acuity, they did not have 
significant visual improvement. We could hypothesize that 
PDT might increase the chance of visual improvement in 
myopic CNV patients, especially in the younger patient 
group. However, our study had a shorter follow-up period 
and our patients had a smaller mean refractive error. 
In our 12-month multivariable regression model, the age 
of patients at onset significantly influenced their visual 
outcome, and a dark rim was another covariate significantly 
affecting the end results. We also found that this dark rim 
was more prominent as the CNV regressed with PDT during 
follow-up (Figure 1). We are the first group to study the dark 
rim as a predictive factor for visual outcome in CNV. 
Histologically, a dark rim corresponds to the multilayered, 
proliferated retinal pigment epithelium at the outer margin of 
the neovascular membrane.18,21 If large parts of the CNV 
remained unperfused for several weeks after PDT, the 
adjacent RPE cells may benefit from the interval required for 
the restoration of the CNV, and they could also migrate and 
proliferate around the vascular net.32 We postulated that 
patients with a dark rim had more potent regenerative 
potential of RPE and received a greater benefit from PDT. 
It was thought that the dark rim found on the baseline ICG 
angiography could be another indicator of the potent 
regenerative potential of RPE. 
In age-related macular degeneration, the visual prognosis 
after PDT is related to the fluorescein angiographic subtype 
of CNV.19-20 The size of the CNV is also related to the 
prognosis. However, in myopic CNV, the relationship 
between the size of the CNV and visual outcome has not 
been fully determined.6-10,25 In our series, there was no 
significant relationship between size and visual outcome. 
New vessels originating from the choroids and the 
hemodynamic characteristics of new vessels must depend on 
those of the choroids. In eyes with severely decompressed 
choriocapillaries, the size and activity of neovascularization 
might be decreased. The visual prognosis could not only be 
influenced by the characters of the CNV but also by the state 
of the choroids and the choriocapillaries. This could obscure 
the relationship between the two.
Lacquer cracks are imaged using enhanced delineation 
with late phase ICG angiography.16,22 There were a few 
reports regarding the pathophysiological relationship between 
lacquer cracks, CNV and visual outcomes.22,33 However, in 
our results the presence of lacquer cracks had no significant 
effect on visual outcome after PDT. 
There have been reports that an anatomic connection of the 
choroids with the arteries or veins is a factor influencing the 
natural course of CNV.16,23,34,35 We postulated that the visible 
prominent choroidal veins in the macula may reflect a 
thinned choroidal vasculature, which may in turn affect the 
visual prognosis of myopia. In our study, there were no 
significant relationships between the presence of a choroidal 
vein and the visual outcomes at the 12- and 24-month 
follow-ups (data not shown). In the univariate analysis of 
choroidal vessels on 24-month follow-up, the presence of a 
prominent choroidal vein in the macula correlated with a 
decrease in visual acuity, even though it was not significant 
(p=0.090). This relationship was the third-smallest p-value 
have an influence on the change in the logMAR value after 
24 months, and it might be more prominent if it were to be 
examined over a longer period of time. 
Our study, however, has its own limitations, including a 
small sample size, a short follow-up period and no com-
parative control group. Prevention of later chorioretinal 
atrophy development and further visual decrease over the 
long-term could not be assessed.36 Patients' ages at onset and 
ICG angiographic features (dark rim) were the significant 
prognostic indicators of the visual outcome after PDT in our 
study. In conclusion, younger patients and patients with a 
dark rim on ICG angiography had a higher chance of visual 
improvement after PDT in myopic CNV.
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